Dataset Information

Discovery, Synthesis, and Preclinical Characterization of N-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4).

ABSTRACT: The efficacy of positive allosteric modulators (PAMs) of the metabotropic glutamate receptor 4 (mGlu4) in preclinical rodent models of Parkinson's disease has been established by a number of groups. Here, we report an advanced preclinically characterized mGlu4 PAM, N-(3-chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506). We detail the discovery of VU0418506 starting from a common picolinamide core scaffold and evaluation of a number of amide bioisosteres leading to the novel pyrazolo[4,3-b]pyridine head group. VU0418506 has been characterized as a potent and selective mGlu4 PAM with suitable in vivo pharmacokinetic properties in three preclinical safety species.

SUBMITTER: Engers DW

PROVIDER: S-EPMC5031509 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Discovery, Synthesis, and Preclinical Characterization of N-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4).

Engers Darren W DW Blobaum Anna L AL Gogliotti Rocco D RD Cheung Yiu-Yin YY Salovich James M JM Garcia-Barrantes Pedro M PM Daniels J Scott JS Morrison Ryan R Jones Carrie K CK Soars Matthew G MG Zhuo Xiaoliang X Hurley Jeremy J Macor John E JE Bronson Joanne J JJ Conn P Jeffrey PJ Lindsley Craig W CW Niswender Colleen M CM Hopkins Corey R CR

ACS chemical neuroscience 20160503 9

The efficacy of positive allosteric modulators (PAMs) of the metabotropic glutamate receptor 4 (mGlu4) in preclinical rodent models of Parkinson's disease has been established by a number of groups. Here, we report an advanced preclinically characterized mGlu4 PAM, N-(3-chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506). We detail the discovery of VU0418506 starting from a common picolinamide core scaffold and evaluation of a number of amide bioisosteres leading to the novel py ...[more]

PMID: 27075300

Dataset Information

Discovery, Synthesis, and Preclinical Characterization of N-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4).

Publications

Discovery, Synthesis, and Preclinical Characterization of N-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4).

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Similar Datasets

1H-Pyrazolo[4,3-g]benzothia-zol-7-amine.
| S-EPMC2977731 | biostudies-literature

Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas.
| S-EPMC6673797 | biostudies-literature

2-Chloro-5-nitro-pyridin-4-amine.
| S-EPMC3344641 | biostudies-literature

3-(5-Chloro-naphthalene-1-sulfonamido)-2-(2-hy-droxy-eth-yl)-4,5,6,7-tetra-hydro-2H-pyrazolo-[4,3-c]pyridin-5-ium chloride.
| S-EPMC3089121 | biostudies-literature

3-Chloro-5-(trifluoro-meth-yl)pyridin-2-amine.
| S-EPMC2960342 | biostudies-literature

N-(3-Chloro-phen-yl)-3-nitro-pyridin-2-amine.
| S-EPMC3247465 | biostudies-literature

5,6-Dimethyl-4-(thio-phen-2-yl)-1H-pyrazolo-[3,4-b]pyridin-3-amine.
| S-EPMC3295413 | biostudies-literature

Radiosynthesis and evaluation of an 18F-labeled positron emission tomography (PET) radioligand for metabotropic glutamate receptor subtype 4 (mGlu4).
| S-EPMC4230996 | biostudies-literature

6-Chloro-3-nitro-N-(propan-2-yl)pyridin-2-amine.
| S-EPMC3120349 | biostudies-literature